NCT00877929View on ClinicalTrials.gov

Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

706

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

May 31, 2010

Conditions
Hypertension
Interventions
DRUG

Telmisartan 80

Telmisartan 80 mg

DRUG

Amlodipine 10

Amlodipine 5 for two weeks, then forced titration to Amlodipine 10

DRUG

Amlodipine 10

Amlodipine 5 for two weeks, then forced titration to Amlodipine 10

Trial Locations (65)

Unknown

1235.21.901 Boehringer Ingelheim Investigational Site, Long Beach

1235.21.907 Boehringer Ingelheim Investigational Site, Tustin

1235.21.913 Boehringer Ingelheim Investigational Site, Fort Lauderdale

1235.21.910 Boehringer Ingelheim Investigational Site, Hollywood

1235.21.903 Boehringer Ingelheim Investigational Site, Pembroke Pines

1235.21.905 Boehringer Ingelheim Investigational Site, Tucker

1235.21.916 Boehringer Ingelheim Investigational Site, Olive Branch

1235.21.915 Boehringer Ingelheim Investigational Site, Hickory

1235.21.906 Boehringer Ingelheim Investigational Site, Winston-Salem

1235.21.902 Boehringer Ingelheim Investigational Site, Oklahoma City

1235.21.904 Boehringer Ingelheim Investigational Site, Penndel

1235.21.908 Boehringer Ingelheim Investigational Site, Carrollton

1235.21.909 Boehringer Ingelheim Investigational Site, Dallas

1235.21.912 Boehringer Ingelheim Investigational Site, Killeen

1235.21.911 Boehringer Ingelheim Investigational Site, Ettrick

1235.21.102 Boehringer Ingelheim Investigational Site, Capital Federal

1235.21.103 Boehringer Ingelheim Investigational Site, Capital Federal

1235.21.107 Boehringer Ingelheim Investigational Site, Ramos Mejía

1235.21.101 Boehringer Ingelheim Investigational Site, Santa Fe

1235.21.105 Boehringer Ingelheim Investigational Site, Zárate

1235.21.302 Boehringer Ingelheim Investigational Site, Acapulco

1235.21.304 Boehringer Ingelheim Investigational Site, Aguascalientes

1235.21.301 Boehringer Ingelheim Investigational Site, Guadalajara

1235.21.303 Boehringer Ingelheim Investigational Site, Guadalajara

1235.21.305 Boehringer Ingelheim Investigational Site, Guadalajara

1235.21.306 Boehringer Ingelheim Investigational Site, Guadalajara

1235.21.408 Boehringer Ingelheim Investigational Site, Beek en Donk

1235.21.401 Boehringer Ingelheim Investigational Site, Hoogwoud

1235.21.405 Boehringer Ingelheim Investigational Site, Musselkanaal

1235.21.404 Boehringer Ingelheim Investigational Site, Nijverdal

1235.21.403 Boehringer Ingelheim Investigational Site, Oude Pekela

1235.21.409 Boehringer Ingelheim Investigational Site, Roelofarensveen

1235.21.406 Boehringer Ingelheim Investigational Site, The Hague

1235.21.407 Boehringer Ingelheim Investigational Site, Voerendaal

1235.21.402 Boehringer Ingelheim Investigational Site, Wildervank

1235.21.501 Boehringer Ingelheim Investigational Site, Bratislava

1235.21.502 Boehringer Ingelheim Investigational Site, Bratislava

1235.21.503 Boehringer Ingelheim Investigational Site, Bratislava

1235.21.504 Boehringer Ingelheim Investigational Site, Bratislava

1235.21.507 Boehringer Ingelheim Investigational Site, Dunajská Streda

1235.21.509 Boehringer Ingelheim Investigational Site, Martin

1235.21.505 Boehringer Ingelheim Investigational Site, Nitra

1235.21.506 Boehringer Ingelheim Investigational Site, Nitra

1235.21.508 Boehringer Ingelheim Investigational Site, Rimavská Sobota

1235.21.27005 Boehringer Ingelheim Investigational Site, Cape Town

1235.21.27007 Boehringer Ingelheim Investigational Site, Cape Town

1235.21.27004 Boehringer Ingelheim Investigational Site, Durban

1235.21.27006 Boehringer Ingelheim Investigational Site, Johannesburg

1235.21.27002 Boehringer Ingelheim Investigational Site, Krugersdorp

1235.21.27001 Boehringer Ingelheim Investigational Site, Lenasia

1235.21.27003 Boehringer Ingelheim Investigational Site, Pretoria

1235.21.202 Boehringer Ingelheim Investigational Site, Incheon

1235.21.201 Boehringer Ingelheim Investigational Site, Seoul

1235.21.203 Boehringer Ingelheim Investigational Site, Seoul

1235.21.204 Boehringer Ingelheim Investigational Site, Seoul

1235.21.205 Boehringer Ingelheim Investigational Site, Seoul

1235.21.702 Boehringer Ingelheim Investigational Site, Castellon

1235.21.705 Boehringer Ingelheim Investigational Site, Centelles

1235.21.703 Boehringer Ingelheim Investigational Site, Sant Adrià Del Besós

1235.21.704 Boehringer Ingelheim Investigational Site, Santa Coloma de Gramanet (Barcelona)

1235.21.706 Boehringer Ingelheim Investigational Site, Santa Coloma de Gramanet

1235.21.801 Boehringer Ingelheim Investigational Site, Gothenburg

1235.21.803 Boehringer Ingelheim Investigational Site, Helsingborg

1235.21.804 Boehringer Ingelheim Investigational Site, Lund

1235.21.802 Boehringer Ingelheim Investigational Site, Västerås

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY